Tuesday, 04 Nov 2025

MedPulse360

Highlighting Research Progress in Tau-Targeting Therapy for Alzheimer Disease: Diana Gallagher, MD
13 September, 2025

NaV1.8 Pain Signal Inhibitor VX-993 Fails to Show Efficacy in Phase 2 Trial of Acute Pain
13 September, 2025

Targeting SIGLEC10 With ONC-841: A Novel Mechanism in Alzheimer Disease Treatment
13 September, 2025

Donanemab Receives CHMP Positive Opinion as Treatment for Early Symptomatic Alzheimer Disease
13 September, 2025

Symptoms and Disease Progression in Pediatric Patients With Dravet Syndrome
13 September, 2025

Role of SCN1A Genetic Testing in Diagnosis of Dravet Syndrome
13 September, 2025

Openwater’s LIFU Technology at MIT: A New Era for Consciousness and Neurological Care
13 September, 2025

Advancing Neurodegenerative Disease Research With Innovative Targets and Platforms: Xiao Xu, PhD; Mark Carlton, PhD
13 September, 2025

Episode 147: Improving Quality of Life in Movement Disorders Through Nonmotor Symptom Management
13 September, 2025

Monitoring Long-Term Efficacy of Migraine Wearable Device Over 3 Years: Alit Stark-Inbar, PhD
13 September, 2025
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago